You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 13, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Michael G Kapteyn1, Anirban Chaudhuri2, Ernesto A B F Lima2,3
1Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin, Austin, TX, USA. michael.kapteyn@austin.utexas.edu.
TumorTwin is a new software framework for creating patient-specific cancer digital twins. It enables dynamic recalibration and supports clinical decisions for optimal cancer treatment strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: